Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for significant upside.

Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, despite challenges in Medicaid cost trends.

Please go ahead. Good morning, and welcome to Elevance Health fourth-quarter 2024 earnings conference call. My name is Nathan Rich, Vice President of Investor Relations. With us this morning on ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look ...

Please go ahead. Good morning, and welcome to Elevance Health's fourth quarter 2024 earnings call. My name is Nathan Rich, Vice President of Investor Relations. With us this morning on the ...

Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded ...

Please go ahead. Nathan Rich-- Vice President, Investor Relations Good morning, and welcome to Elevance Health fourth quarter 2024 earnings call. My name is Nathan Rich, vice president of investor ...

Elevance Health Inc. (NYSE:ELV) Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8. Operator ...